Groowe Groowe / Newsroom / KROS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

KROS News

Keros Therapeutics, Inc. Common Stock

A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday

prnewswire.com
AGIO KROS PTGX IRON SLN

Form 8-K

sec.gov
KROS

Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda

globenewswire.com
KROS

CBB 2026 Set for a Grand Opening | Leading Exhibitors Across the Entire Industry Chain to Gather in Shanghai This October Ready to Announce with Confidence?

newsfilecorp.com
KROS EH BH

Form 8-K

sec.gov
KROS

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD

globenewswire.com
KROS

Form 8-K

sec.gov
KROS

Keros Therapeutics Announces $5 Million Share Repurchase Authorization

globenewswire.com
KROS

CBB 2026: Global Liquid Food Industry Chain Event to Open in Shanghai This October

globenewswire.com
KROS

Packaging and Labelling Machine Market Report 2026–2035: Evaluating $89.3 Billion Forecast, RFID Print-and-Apply Systems, and Strategies of Krones, Syntegon, IMA Group, and Coesia

globenewswire.com
KROS SIG